In a welcome move, Surgery Partners stock saw its Relative Strength Rating improve from 65 to 77 on Tuesday.
When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
This proprietary rating measures technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the market's biggest winners typically have an RS Rating of at least 80 in the early stages of their moves. See if Surgery Partners stock can continue to show renewed price strength and hit that benchmark.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Surgery Partners Stock A Buy?
Surgery Partners stock has risen more than 5% past a 16.02 entry in a first-stage cup without handle, meaning it's now out of a proper buy zone. Look for the stock to offer a new chance to get in like a three-weeks tight or pullback to the 50-day or 10-week line. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The hospital operator reported 0% earnings growth last quarter, while sales growth came in at 11%. The next quarterly results are expected on or around Mar. 1.
Surgery Partners stock holds the No. 7 rank among its peers in the Medical-Hospitals industry group. HCA Healthcare and Tenet Healthcare are also among the group's highest-rated stocks.
